News & Events

Leica Biosystems announced the integration of its Cerebro Sample Tracking System with Psyche Systems’ WindoPath and NucleoLIS products. The aim of this collaboration is to increase the efficiency and quality of laboratory pathology services by reducing the number of clicks and…

The future of the lab is not inside the LIS…it is outside. Performing a laboratory test is now a commodity, a place where high quality and efficiency are assumed features, not extra values had at a premium. So, much like…

Now you can streamline the diagnostically diverse complexities of Molecular testing. NucleoLIS is a fully automated solution for PCR, Immunology, FISH, Karyotyping and DNA sequencing designed to support the unique workflow, deviations, reflexing and the complex reporting requirements of the…

When it comes to adopting any form of information technology (IT), the healthcare sector has a well-earned reputation for being careful, conservative, and glacially slow. Even with significant carrot-and-stick incentives from both government and private payors, IT-based systems have been…

While clinical laboratory testing as a diagnostic tool continues to grow in influence and importance to the majority of medical decision making, ongoing changes in the health care industry are providing new challenges, including disruptive business models and technology, engaged…

Psyche Systems and Luminate Health have formed a strategic alliance offering a platform that helps labs comply with new federal HHS legislation regarding patient access to lab results. The platform transforms the way patients engage with results and improves provider…

or over 35 years, Psyche Systems has been delivering products and services to help laboratories of all sizes and types run more efficiently and cost-effectively. Psyche's unified laboratory information system, WindoPath®, for clinical, anatomic pathology and molecular labs, MicroPath® laboratory…

Negotiating SaaS contracts: what to do and what to avoid As the trend in cloud computing continues, in part as a way to reduce capital investment costs, laboratory decision-makers must learn the nuances of how to vet this type of…